Brain-derived neurotrophic factor and insulin resistance during hyperinsulinaemic-euglycaemic clamp in type 1 diabetes patients in the PoProStu

Diabetes Metab. 2017 Oct;43(5):472-474. doi: 10.1016/j.diabet.2016.12.007. Epub 2017 Jan 27.

Authors

A Uruska¹, P Niedzwiecki², A Araszkiewicz², D Zozulinska-Ziolkiewicz²

Affiliations

¹ Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Raszeja Hospital, Mickiewicza 2, 60-834 Poznan, Poland. Electronic address: aleksandrauruska@gmail.com.
² Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Raszeja Hospital, Mickiewicza 2, 60-834 Poznan, Poland.

PMID: 28139435
DOI: 10.1016/j.diabet.2016.12.007

No abstract available

Publication types

Letter

MeSH terms

Adult
Blood Glucose / metabolism*
Brain-Derived Neurotrophic Factor / blood*
Diabetes Mellitus, Type 1 / blood*
Diabetes Mellitus, Type 1 / drug therapy
Female
Glucose Clamp Technique
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Insulin Resistance / physiology*
Male

Substances

Blood Glucose
Brain-Derived Neurotrophic Factor
Hypoglycemic Agents
Insulin